Abstract
Data from the scientific literature on the current state of the spread of dependence on psychoactive substances of plant origin – cannabinoids was processed. The problem of cannabinoid addiction has been studied. Forensic and pharmaceutical practice was analyzed. The development of organizational measures in order to provide drug patients with cannabinoid addiction (F12) with a comprehensive approach was substantiated. The peculiarities of pharmacotherapy and the availability of drugs for drug addicts have been clarified. The methods of assessing the availability and effectiveness of hepatoprotectors based on pharmacoeconomic, forensic and pharmaceutical indicators have been improved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
